COPAN
2175 Sampson Avenue
Suite 124
Corona
California
92879
United States
Tel: 951-549-8793
Fax: 951-549-8850
Website: http://www.copanusa.com/
19 articles about COPAN
-
Copan Diagnostics Announces Leadership Change - February 02, 2023
2/2/2023
COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics' board of directors effective from January 9th, 2023.
-
COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology
1/19/2022
On the heels of recent news of FDA clearance for Colibri™, automated colony picking instrument for identification and antimicrobial susceptibility testing in clinical Microbiology, today COPAN announced the North American launch of PhenoMATRIX® TAG.
-
Microbix & Copan Italia Execute Strategic AgreementFor FLOQ devices & QAPs Co-branding, IP licensing, Co-marketing, Purchase and Supply
12/21/2020
Microbix Biosystems Inc., a life sciences innovator and exporter, and Copan Italia S.p.A., the global leader in specimen collection technologies, announce their execution of a strategic agreement in relation to Microbix’s quality assessment products and Copan’s flocked devices.
-
COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar's COLOREX™ Media
6/14/2019
COPAN and Alverno Laboratories are proud to announce the successful evaluation of the novel COLOREX™ Strep A chromogenic medium using Artificial Intelligence and digital detection to pre-assess Throat Strep Screens in WASPLab™.
-
COPAN Maintains Its Global Commitment To Address Unauthorized Use Of Its Patented Technology
1/16/2019
The German Supreme Court has denied COPAN's request that the German Patent Court conduct a new hearing concerning the Patent Court's decision, in 2016, to revoke COPAN's utility model DE'930.
-
COPAN Announces Lawsuit for Patent Infringement and Unfair Competition Against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC
6/4/2018
COPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics, Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779.
-
TriCore Reference LaboratoriesAnd COPAN Announce Strategic Alliance With The Implementation Of Wasplab
5/13/2016
-
Unprecedented Multi-Center Study Shows COPAN's WASPLab Image Analysis Software's Robust Ability To Automatically Detect MRSA On Chromogenic Agar
2/18/2016
-
COPAN Is Proud To Announce FDA Clearance For FecalSwab To Standardize And Simplify Enteric Culture And Molecular Diagnostics
5/13/2015
-
Two New US Patents Protect COPAN Invention Of Flocked Swabs
4/24/2015
-
COPAN Release: UTM™ Available This Flu Season
1/17/2013
-
As Influenza Season Unfolds, COPAN Offers Free Educational Respiratory Sample Collection Videos for Healthcare Providers
1/7/2013
-
US Patent Office Grants COPAN Invention of Flocked Swabs
12/22/2011
-
COPAN Announces Workshop on Automated Specimen Processing, Digital Workup and Reporting in Microbiology During AACC Clinical Lab Expo
7/20/2011
-
China Grants COPAN Patent for Flocked Swabs
6/28/2011
-
COPAN Announces the Launch of WASPLab™
4/29/2011
-
COPAN Secures Japanese Patent for its Flocked Swab Innovation
9/13/2010
-
Copan Diagnostics, Inc. Offers Kit for Rapid Collection of Nasopharyngeal Sample to Detect Swine Flu Virus
4/28/2009
-
Friedrich Miescher Institute Release: Leading Life Science Research Institute Chooses COPAN Systems Enterprise MAID Storage Solution
10/29/2008